Peter W Hunt Selected Research

Peter W Hunt Research Topics

Disease

39	HIV Infections (HIV Infection) 03/2023 - 12/2006
37	Inflammation (Inflammations) 05/2023 - 04/2010
34	Acquired Immunodeficiency Syndrome (AIDS) 05/2024 - 03/2010
27	Infections 11/2023 - 01/2012
20	Viremia 01/2023 - 09/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 03/2010
10	Disease Progression 06/2022 - 03/2006
7	Tuberculosis (Tuberculoses) 03/2024 - 09/2011
5	Macular Degeneration (Age-Related Maculopathy) 05/2024 - 01/2018
5	Neoplasms (Cancer) 10/2023 - 03/2010
4	Myocardial Infarction 01/2023 - 09/2009
4	Fibrosis (Cirrhosis) 01/2018 - 04/2015
4	Atherosclerosis 06/2012 - 06/2009
3	Pneumonia (Pneumonitis) 03/2024 - 01/2019
3	COVID-19 10/2022 - 01/2022
3	Hepatitis C 01/2019 - 11/2013
3	Sepsis (Septicemia) 01/2019 - 01/2017
2	Cataract (Cataracts) 05/2024 - 01/2022
2	Fatigue 01/2023 - 07/2022
2	Alcoholism (Alcohol Abuse) 03/2022 - 12/2015
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Coinfection 01/2022 - 01/2017
2	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2021 - 11/2015
2	Insulin Resistance 01/2019 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2017
2	Persistent Infection 01/2019 - 01/2017
2	Necrosis 01/2018 - 01/2012
2	Hypertension (High Blood Pressure) 12/2016 - 10/2015
2	Carotid Artery Diseases 02/2016 - 06/2012
1	Latent Tuberculosis 01/2024
1	Rupture 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Coronary Thrombosis 01/2023
1	Nematode Infections 04/2022
1	Zika Virus Infection 01/2022
1	Genetic Risk Score 10/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Tics (Tic) 01/2020
1	Lung Injury 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Ischemic Stroke 01/2019

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2010
14	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2004
12	KynurenineIBA 01/2024 - 07/2013
11	Interleukin-6 (Interleukin 6)IBA 05/2024 - 07/2013
10	Tryptophan (L-Tryptophan)FDA Link 01/2024 - 07/2013
9	C-Reactive ProteinIBA 05/2024 - 04/2012
9	Lipopolysaccharide ReceptorsIBA 05/2024 - 10/2014
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2016
7	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2011
6	CytokinesIBA 10/2022 - 07/2013
5	AntigensIBA 01/2024 - 04/2012
5	fibrin fragment D (D-dimer)IBA 05/2023 - 10/2014
4	Oxygen (Dioxygen)IBA 01/2023 - 01/2017
4	Immunoglobulin G (IgG)IBA 01/2023 - 06/2012
4	VaccinesIBA 12/2014 - 05/2008
4	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 03/2006
3	InterleukinsIBA 03/2024 - 01/2019
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2024 - 10/2014
3	LipidsIBA 03/2023 - 10/2020
3	Interleukin-17 (Interleukin 17)IBA 01/2023 - 05/2010
3	Fatty Acid-Binding ProteinsIBA 01/2022 - 01/2019
3	Peptide Hydrolases (Proteases)FDA Link 11/2021 - 03/2006
3	Retinaldehyde (Retinal)IBA 01/2019 - 07/2017
2	LigandsIBA 03/2024 - 05/2008
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2023 - 07/2022
2	Carbon MonoxideIBA 01/2023 - 01/2021
2	phosphatidylethanolIBA 03/2022 - 12/2015
2	Neutralizing AntibodiesIBA 01/2022 - 12/2016
2	InterferonsIBA 01/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2010
2	AntibodiesIBA 12/2019 - 05/2019
2	BilirubinIBA 01/2019 - 01/2018
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2019 - 01/2018
2	abacavir (Ziagen)FDA Link 10/2017 - 09/2009
1	Interleukin-18 (Interleukin 18)IBA 05/2024
1	InflammasomesIBA 05/2024
1	Chemokine CX3CL1IBA 05/2024
1	ChemokinesIBA 03/2024
1	staphylococcal enterotoxin BIBA 01/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2023
1	Angiopoietin-2IBA 01/2023
1	4-toluenesulfonyl fluoride (TSF)IBA 04/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	ruxolitinibIBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	T Cell Transcription Factor 1IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Integrase InhibitorsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019
1	Matrix Metalloproteinases (MMPs)IBA 10/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	CHDI-340246IBA 01/2019

Therapy/Procedure

47	Therapeutics 03/2024 - 09/2003
34	Art Therapy 01/2022 - 03/2010
6	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 10/2010
1	Bed Rest (Bedrest) 11/2023